No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ZTS240517P155000
- 0.08
- -0.11-57.89%
15min DelayClose May 10 16:00 ET
0.42High0.08Low
0.42Open0.19Pre Close2 Volume2.92K Open Interest155.00Strike Price50.00Turnover39.15%IV-8.39%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.08Time Value100Contract SizeAmericanOptions Type-0.0417Delta0.0103Gamma1126.93Leverage Ratio-0.0559Theta-0.0011Rho-47.00Eff Leverage0.0198Vega
Intraday
- 5D
- 1D
News
U.S. Pledges Nearly $200M to Prevent Bird Flu Spread on Dairy Farms
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2024 Earnings Call Transcript
Express News | NYSE Order Imbalance 56002.0 Shares on Buy Side
Express News | NYSE Order Imbalance 122635.0 Shares on Buy Side
Zoetis Is Maintained at Buy by HSBC
Zoetis Is Maintained at Buy by HSBC
Zoetis Price Target Cut to $225.00/Share From $230.00 by HSBC
Zoetis Price Target Cut to $225.00/Share From $230.00 by HSBC
Comments
$Zoetis(ZTS.US$ I got an call option a month out on friday soon as I heard the news!
1
2
Zoetis' market sentiment remains steady, with share price reflecting EPS growth. Over five years, returns improve, indicating the share price may pause as the business pursues its growth strategy.
Piper Sandler analysts find Boston Scientific, Expedia Group, Progressive Corporation, Skechers U.S.A., Synovus Financial, and Zoetis Inc. stocks attractive due to their individual strengths and positive trends.
The stock shows promising signs with profitable growth and substantial insider ownership, indicating aligned interests between shareholders and management. Investors are advised to keep Zoetis on their watchlist while also being aware of any potential warning signs.
Read more